Sharechat Logo

Smith leaves Wrightson board

By Phil Boeyen, ShareChat Business News Editor

Thursday 31st January 2002

Text too small?
Wrightson (NZSE: WRI) independent director Mike Smith is to stand down from the board following his high profile resignation from dairy giant Fonterra (NZSE: FCGHA).

Mr Smith resigned from his role at Fonterra earlier this month, citing concerns over governance at one of the world's largest dairy companies.

He was appointed to the Wrightson board last year after Fonterra subsidiary, RD1.COM, took a 19.9% stake in the listed rural services company.

"Given the association between my directorship of Wrightson and my involvement with Fonterra, it is appropriate that having resigned my Fonterra directorship, I should also resign my Wrightson directorship", says Mr Smith.

"I leave with considerable regret, as the company is performing well, has a good future, and I have enjoyed my time at the board table."

Wrightson chairman, John Palmer, says although Mr Smith was nominated as a director by RD1.COM in recognition of its shareholding in Wrightson, he was appointed by the Wrightson directors as an independent director.

He says that Mr Smith had brought a valuable combination of experience and expertise to the board, which would be missed by the directors and management.

Mr Palmer says the board had no immediate plans to fill the vacancy left by Mr Smith.

  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

Farming provides economic safe harbour
Special Report: Greener Pastures For Rural Stocks
Wrightson looks to bio-tech field for growth